ICM
CLS icon

Invenomic Capital Management’s Celestica CLS Stock Holding History

Invenomic Capital Management’s Portfolio CLS Stock Details CLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-753,222
Closed -$9.72M – 139
2023
Q1 		$9.72M Sell
753,222
-699,068
-48% -$8.94M 0.55% 59
2022
Q4 		$16.4M Sell
1,452,290
-29,791
-2% -$313K 1.11% 25
2022
Q3 		$12.5M Buy
1,482,081
+209,196
+16% +$2.12M 1.07% 32
2022
Q2 		$12.4M Buy
1,272,885
+305,849
+32% +$3.28M 0.88% 38
2022
Q1 		$9.44M Buy
967,036
+451,968
+88% +$5.33M 1.01% 30
2021
Q4 		$5.73M Sell
515,068
-21,327
-4% -$221K 1.23% 24
2021
Q3 		$4.76M Buy
536,395
+48,384
+10% +$415K 1.55% 22
2021
Q2 		$3.83M Buy
488,011
+361,319
+285% +$3.02M 0.92% 22
2021
Q1 		$1.06M Sell
126,692
-62,124
-33% -$529K 0.24% 76
2020
Q4 		$1.52M Buy
188,816
+47,682
+34% +$349K 0.39% 55
2020
Q3 		$974K Sell
141,134
-102,381
-42% -$770K 0.54% 58
2020
Q2 		$1.66M Sell
243,515
-6,910
-3% -$39.5K 1.23% 26
2020
Q1 		$877K Sell
250,425
-240,690
-49% -$1.66M 0.72% 52
2019
Q4 		$4.06M Buy
+491,115
New +$3.66M 1.63% 16

Other funds holding CLS

LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's CLS Position: Q2 2023 in Review

Invenomic Capital Management sold out of Celestica (CLS) in Q2 2023, closing a stake of 753,222 shares — an estimated $9.72M sold.

Invenomic Capital Management first reported a position in CLS in Q4 2019 and held it in 14 quarters. The position peaked at $16.4M in Q4 2022. 157 funds tracked by Wall St. Rank hold CLS as of Q2 2023.

  • Invenomic Capital Management reported no remaining Celestica position as of Q2 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 753,222 Celestica shares in Q2 2023, an estimated $9.72M.
  • Invenomic Capital Management first reported a position in Celestica in Q4 2019 and held it in 14 quarters.
  • Invenomic Capital Management's Celestica position peaked at $16.4M in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Celestica as of Q2 2023.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.